QUÉBEC CITY, May 11, 2017 /CNW Telbec/ - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2017, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.
Election of Directors
Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Corporation until the next annual shareholders' meeting. Accordingly, the results are set out below:
|
Name |
Votes for |
% for |
Votes |
% |
Withheld |
% withheld |
| Germain Carrière |
31,583,349 |
86.21 |
0 |
0 |
5,053,411 |
13.79 |
| Pierre Désy |
36,616,660 |
99.95 |
0 |
0 |
20,100 |
0.05 |
| Jean Lamarre |
36,602,792 |
99.91 |
0 |
0 |
33,968 |
0.09 |
| Claude Michaud |
36,605,792 |
99.92 |
0 |
0 |
30,968 |
0.08 |
| Jeffrey Pompeo |
36,594,567 |
99.88 |
0 |
0 |
42,193 |
0.12 |
| Jean-Pierre Robert |
36,605,192 |
99.91 |
0 |
0 |
31,568 |
0.09 |
| Linda Rosentstock |
36,591,224 |
99.88 |
0 |
0 |
45,536 |
0.12 |
| Richard M. Rumble |
36,604,067 |
99.91 |
0 |
0 |
32,693 |
0.09 |
| Steve West |
36,597,424 |
99.89 |
0 |
0 |
39,336 |
0.11 |
Other Proposals
| Appointment of |
41,664,774 |
99.91 |
0 |
0 |
39,404 |
0.09 |
| Amendment of the |
25,569,212
|
69.79 |
11,067,548 |
30.21 |
0 |
0.00 |
Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 10, 2017, will be filed on SEDAR (www.sedar.com) under the name TSO3.
About TSO3
Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
For more information about TSO3, visit the Company's website at www.tso3.com
SOURCE TSO3 Inc.
Company Contacts: TSO3 Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: [email protected]; TSO3 Inc., Glen Kayll, CFO, Tel: 418 651-0003, Email: [email protected]; Investor Relations: Capital Market Access LLC, Ron Both, 949 432-7557, courriel: [email protected]; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, Email: [email protected]
Share this article